US 8772238
Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
granted A61KA61K38/1767A61K38/57
Quick answer
US patent 8772238 (Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/1767, A61K38/57, A61K45/06, A61P